Beyond Celiac is the leading trusted resource on celiac disease. We are available and qualified to speak to the press on a variety of topics including, but not limited to:
- Celiac disease as a serious genetic autoimmune disease
- Health equity in celiac disease
- Celiac disease patient advocacy and patient stories
- The need for treatments beyond the gluten-free diet
- The latest in celiac disease research/science/drug development
- Non-GI symptoms of celiac disease
- Connection to other autoimmune diseases
- Growth of the gluten-free market, gluten-free labeling
Media Inquiries and Partnerships
If you are a member of the media and want to know more about Beyond Celiac, including our research program, Science Plan, patient stories, and more, please contact Stacy Eaton-Carter at [email protected].
Celiac Disease Facts and Information
Check out the resources below for more information on Beyond Celiac, celiac disease and the gluten-free diet:
About Beyond Celiac
Download Founder Alice Bast’s Headshots
Beyond Celiac Brand Elements/Logos
Download Celiac Disease: The Basics (including the gluten-free diet)
Fast Facts about Celiac Disease
Download Fact vs Fiction: Celiac Disease and the Gluten-Free Diet
Read the Beyond Celiac Science Plan
Read stories from real patients in our Voces de la enfermedad celíaca archive
Articles from Beyond Celiac
An Underground World of Parasites – Could this be the Key to Curing Disease?
New York Times writer dives deep into a new phenomenon: treating disease through parasites.
Beyond Celiac to Present Innovative Patient Engagement Model at Stanford Medicine X
Panel workshop will inform attendees about strategies for educating and empowering those with genetic diseases to improve diagnosis rates
Beyond Celiac in the News
-
Quoted
Teva’s Lab-Made Antibody Shot for Celiac Shows Hopeful Results (opens in a new tab)
Allergic Living
-
Quoted
With 3 Federal Bills in Play, Hopes are High for Full Gluten Labeling (opens in a new tab)
Allergic Living
-
Subject
Philadelphia cell therapy company raises $15.1M with local backing (opens in a new tab)
Business Journal